Abivax S.A.
Price Action
Technical Summary
CONSOLIDATINGAbivax S.A. is in a consolidation phase, trading with mixed signals as moving averages converge. Relative strength is leading (RS Rating: 81), indicating clear outperformance against the broad market. Earnings contraction of 40% provides fundamental context to the price action. However, price is extended 25% above the 50-day line, increasing the risk of a mean reversion.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $108.50 | +31.03% | ABOVE |
| 50 SMA | $113.47 | +25.29% | ABOVE |
| 100 SMA | $116.02 | +22.54% | ABOVE |
| 150 SMA | $117.77 | +20.72% | ABOVE |
| 200 SMA | $112.64 | +26.22% | ABOVE |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is ABVX in an uptrend right now?
ABVX has a trend score of 2/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 2 of 4 trend criteria are met.
Is ABVX overbought or oversold?
ABVX's RSI (14) is 70. The stock is in neutral territory, neither overbought nor oversold.
Is ABVX outperforming the market?
ABVX has a Relative Strength (RS) Rating of 81 out of 99. Yes, ABVX is a market leader, outperforming 81% of all stocks over the past 12 months.
Where is ABVX in its 52-week range?
ABVX is trading at $142.17, which is 96% of its 52-week high ($148.83) and 95% above its 52-week low ($7.70).
How volatile is ABVX?
ABVX has a Beta of 1.01 and 52-week volatility of 87%. It's more volatile than the S&P 500 - expect bigger swings.